# Sources — Ann Richards

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 3, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. Morales T. “Ann Richards' Latest Battle.” CBS News, August 11, 2003. Supports that in 1996, after falling twice and breaking her hand and ankle, she had a bone density test; that the diagnosis was osteopenia, “an early stage of osteoporosis”; that she had shrunk three-quarters of an inch; that she asked for the test at a yearly checkup because of her mother; that she said osteoporosis was not the cause of her mother's death but led to it; that she took a medicine, began weight-bearing exercise, and changed her sleep and diet; that her bone density had stabilized; and that she was a spokesperson for the maker of her medicine. https://www.cbsnews.com/news/ann-richards-latest-battle
2. CBS News report on Ann Richards and osteoporosis, November 30, 2000. Supports her account that her mother had osteoporosis, broke “her arm, her hip,” and developed a hump; that she asked her doctor to test her bone density; that she began lifting weights; and that she took a medicine and changed her diet. https://www.cbsnews.com/news/ann-richards-osteoporosis-campaign/
3. CNN. Larry King Live transcript, May 14, 2002. Her own words: her mother “broke one bone after another,” she asked for a bone density examination at her annual checkup, “my neck bones were collapsing and I literally was shrinking,” and weight-bearing exercise builds bone density. https://transcripts.cnn.com/show/lkl/date/2002-05-14/segment/00
4. Publishers Weekly. Review of *I'm Not Slowing Down: Winning My Battle with Osteoporosis* (Dutton, 2003), written with Richard U. Levine, MD. Supports her osteopenia found after a 1994 hand fracture led to a bone density test, her mother's illness, and her spokesperson role. https://www.publishersweekly.com/9780525946915
5. Texas Cooking. Book description of *I'm Not Slowing Down*. Supports that in 1996, after falling and fracturing her hand, she had a bone density test and was diagnosed with osteopenia, an early stage of osteoporosis, and that she began medicine and exercise and changed her habits. https://texascooking.com/books/osteoporosisannrichards.htm
6. Texas State Library and Archives Commission. Governor Ann W. Richards biography. Supports her heavy drinking in her own words (“I smoked like a chimney and drank like a fish”), that she entered treatment and emerged sober, her election as state treasurer in 1982, the 1988 convention keynote, and her election as governor. https://www.tsl.texas.gov/governors/modern/richards-p01.html
7. EBSCO Research Starters. Ann Richards. Supports her birth as Dorothy Ann Willis in Lakeview, near Waco; treatment for alcoholism in 1980, described as successful; esophageal cancer found in March 2006; and her death on September 13, 2006. https://www.ebsco.com/research-starters/biography/ann-richards/
8. Texas State Cemetery. Ann Willis Richards plot holder record, with the Associated Press obituary. Supports her birth on September 1, 1933, and her death on September 13, 2006, at her home in Austin. https://cemetery.texas.gov/locate-a-plot/plotholder/ann-willis-richards
9. Associated Press obituary, via The Spokesman-Review, September 14, 2006. Supports that esophageal cancer was found in March, that she had chemotherapy, that she served one term as governor and lost her bid for re-election, and the 1988 keynote address. https://www.spokesman.com/stories/2006/sep/14/ann-richards-dies-at-73
10. HISTMED Master Roster v3. Internal project source. Its clinical claims were provisional and were not treated as independent corroboration.

## Clinical guidance

1. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), osteoporosis monograph. Baseline secondary-causes tests (calcium, 25-hydroxyvitamin D, PTH, alkaline phosphatase, creatinine and eGFR, phosphate, magnesium, TSH, blood count, 24-hour urine calcium); vitamin D corrected before an antiresorptive; calcium before each intravenous dose; CTX at baseline and 3 to 6 months after starting; DXA every 1 to 2 years on therapy (AACE) or 1 to 3 years (Endocrine Society); vertebral fracture assessment after a recent low-trauma fracture or height loss; yearly height and fall-risk screen; FRAX recalculated when risk changes, with treatment at 20 percent major osteoporotic or 3 percent hip; calcium 1200 mg a day for women over 50 and vitamin D 800 to 1000 units; drug-holiday reassessment after 3 years of zoledronic acid. https://patrickrutledge.github.io/topthirty/
2. LeBoff MS et al. The clinician's guide to prevention and treatment of osteoporosis (Bone Health and Osteoporosis Foundation). *Osteoporos Int* 2022;33(10):2049-2102. Treatment thresholds, calcium and vitamin D, exercise, falls prevention, and vertebral imaging. https://pubmed.ncbi.nlm.nih.gov/35478046/
3. Camacho PM et al. AACE/ACE Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis, 2020 Update. *Endocr Pract* 2020;26(Suppl 1):1-46. Clinical diagnosis of osteoporosis in low bone mass with high FRAX risk, high and very-high-risk categories, initial drug choices, DXA every 1 to 2 years, and drug-holiday rules. https://pubmed.ncbi.nlm.nih.gov/32427503/
4. Eastell R et al. Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline. *J Clin Endocrinol Metab* 2019;104(5):1595-1622. https://pubmed.ncbi.nlm.nih.gov/30907953/
5. Shoback D et al. Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update. *J Clin Endocrinol Metab* 2020;105(3):587-594. https://pubmed.ncbi.nlm.nih.gov/32068863/
6. U.S. Preventive Services Task Force. Osteoporosis to Prevent Fractures: Screening (2025); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening
7. Centers for Disease Control and Prevention. STEADI: Stopping Elderly Accidents, Deaths, and Injuries. https://www.cdc.gov/steadi/index.html
8. VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021), and for the Assessment and Management of Patients at Risk for Suicide (2024). https://www.healthquality.va.gov/guidelines/MH/sud/
9. Medicare Preventive Services reference (Aether Forge, 2026); U.S. Preventive Services Task Force A and B recommendations, including breast (2024), cervical (2018), colorectal (2021), and lung cancer (2021) screening, statin use (2022), diabetes screening (2021), depression screening (2023), and unhealthy alcohol use (2018); CDC Adult Immunization Schedule by Age. https://patrickrutledge.github.io/preventative_services/

## Editorial resolutions

- **Recent-death rule.** Richards died in 2006. The case uses only what she made public herself (her 2003 book as described in reviews, her television interviews, and press coverage of her osteoporosis), her public account of heavy drinking and recovery, and basic biographical facts from state archives and obituaries. No medical records, physician statements, family accounts, or speculation about undisclosed conditions are used. Everything clinical in the modern episode is synthetic: her DXA T-scores, FRAX, laboratory results, vertebral assessment, fall tests, treatment, and preventive care. Claims about alcohol and tobacco are marked sensitive. No sick visit is added.
- **Fracture and diagnosis.** The sources agree that she broke her hand in a fall and then had a bone density test. CBS News (2003) and the publisher's book description date this to 1996; the Publishers Weekly review dates the hand fracture to 1994. CBS (2003) alone says she fell twice and also broke her ankle. The case uses 1996 with the conflict recorded, and treats the ankle fracture as reported in one source. The published label is osteopenia, “an early stage of osteoporosis”; in some interviews she said she had osteoporosis. Her T-scores were not found in any fetched source (the book itself was not accessed), so none are used.
- **Precision in the modern episode.** The synthetic T-scores (lumbar spine -2.3, femoral neck -2.0, total hip -1.7) are in the low bone mass range, matching the published osteopenia. The notes say plainly that this is not osteoporosis by T-score and that “early osteoporosis” is not a defined category. Treatment rests on FRAX (22 percent major osteoporotic, 3.6 percent hip, above the 20 and 3 percent thresholds), with her mother's hip fracture (her own public account) and her hand fracture entered. Judgment call: the hand fracture followed a fall from standing height, so it is entered as a previous fracture in FRAX, while the notes explain that a hand fracture does not by itself establish osteoporosis; without it, FRAX would fall below the thresholds. The FRAX values are synthetic estimates, not a recorded calculation from her life. Problem code M85.89 follows the densitometric category; the notes add that AACE 2020 would call this osteoporosis on clinical grounds.
- **Drug choice and the spokesperson role.** She publicly took a prescription medicine and was a spokesperson for its maker. The record names no brand, does not name or use her medicine, and repeats no promotional claim. The synthetic therapy (zoledronic acid once a year) was chosen strictly by AACE 2020, the Endocrine Society, and BHOF for her synthetic risk (hip risk above threshold, so a drug with proven hip fracture reduction), with once-yearly dosing for her travel. The consultant notes, in general terms, that a selective estrogen receptor modulator is not suitable for a woman whose hip risk is above threshold; this is guideline reasoning about the synthetic patient, not a comment on her real care. Calcium from food, vitamin D, weight-bearing and balance exercise, falls prevention, the secondary-causes work-up, DXA two years after starting, and the drug-holiday rules follow the CMID and the cited guidelines.
- **Alcohol use disorder.** Her heavy drinking and recovery are public in her own words and in reference biographies (treatment in 1980). The case codes alcohol use disorder in sustained remission (F10.21), so a structured safety assessment was added at intake with the 988 Suicide & Crisis Lifeline, and safety and recovery are reviewed at every later visit; it records no current risk and makes no claim about her real mental health. Who prompted her treatment is not recorded, because the sources attribute it to relatives and friends. Her past heavy smoking is from her own phrase; the quit timing (more than fifteen years before the index visit) is synthetic, and it decides that she is not eligible for lung cancer screening.
- **Index age.** The modern episode presents Richards at 63, the year after the fall and hand fracture. The synthetic date of birth is September 1, 1962 (shift 29 years). The index visit on February 10, 2026 maps to February 10, 1997; the chronic-care visits on March 10, May 12, and August 11, 2026 map to the same days of 1997; and the adult preventive visit on October 6, 2026 maps to October 6, 1997, when she was 64 (so `preventive_adult`). Every visit falls within her lifetime and after the documented fracture and test. Because she says she had been told of early bone loss after the earlier test and no report is available, the intake DXA serves as a new baseline. The modern record does not model her real treatment after the 1996 test; this is a judgment call for review.
- **Synthetic clinical picture.** Kept modest: no vertebral fracture, normal secondary-causes tests apart from vitamin D insufficiency (24 ng/mL, corrected to 38), normal mood and alcohol screens, no new falls or fractures. The 2 cm height loss matches the three-quarters of an inch reported in the press. The occupation (public speaker and policy adviser), living situation, diet, menopause timing, and vaccines are synthetic. Her later esophageal cancer and death are recorded as history only and are not used in the episode.
- **Focused visits.** The three chronic-care follow-ups (four weeks, three months, and six months after intake) are documented as focused visits on the CMID osteoporosis monograph, with AACE 2020, the Endocrine Society, BHOF 2022, and CDC STEADI, and each lists every item the protocol calls for at that point, with its interval and status. The four-week visit is the day of the endocrinology consultation; the three-month visit has the pre-infusion tests and the first zoledronic acid infusion; the six-month visit has the CTX response check three months after the dose. Protocol deviation recorded instead of an invented result: the 24-hour urine calcium ordered at intake was not collected before the four-week visit because she was traveling, and was collected about ten weeks late, before the first dose, with a normal result, no harm, and a corrective action.
- **Consultation.** The endocrinology referral and the consultation by Marcus Delgado, MD (a fictional consultant), on the day of the four-week visit, are **S**. The consultant answers all six questions in line with what the record shows happened afterwards: low bone mass with FRAX above threshold (AACE very-high-risk because of the injurious fall and recent fracture); zoledronic acid after vitamin D repletion, a normal calcium and eGFR, and a dental examination; the 24-hour urine collected before the first dose; the balance program; CTX at three months after the dose; DXA two years after starting; and a drug-holiday reassessment after three yearly doses.
- **Adult preventive visit.** Added on October 6, 2026 (true frame October 6, 1997), at 64. It includes the health risk assessment, a 12-system review, influenza and PCV20 vaccines, a lipid panel with a statin decision, and screening decisions for breast, cervical, colorectal, and lung cancer, diabetes, hepatitis C and HIV, depression, and alcohol. Advance care planning names an unnamed health care agent and records only general priorities (independence and plain information), with no treatment preference, so nothing reads as a claim about her real choices.
- **Not used.** Her real medicine and its maker, the details of her cancer treatment, her final months, and any family account of her health were not used. The roster's summary was not used as independent evidence.
